Breaking Innovation Paralysis podcast

Worker Bees or Owners? Breaking Canada's Branch-Plant Habit.

0:00
55:19
Rewind 15 seconds
Fast Forward 15 seconds

Daniel Perry is Director of Federal Affairs at the Council of Canadian Innovators (CCI), where he leads national advocacy on behalf of Canada's high-growth scale-up companies. Named to The Hill Times' Top 100 Lobbyists for 2026, he has testified this year before three House of Commons standing committees — Industry and Technology, Finance, and Citizenship and Immigration — each time making the same case: capital, customers, talent, and sectoral strategy aren't separate policy files, they're one connected problem. He holds a Master of Political Management from Carleton University and has written a bi-weekly political column for the Niagara-Hamilton Independent since 2021.

The conversation turns to risk. Perry shares the story of a CCI member who couldn't crack Canadian capital, flew to San Francisco, and closed a deal with an investor over drinks at the airport bar — a deal they said would have taken six to eight months at home. He is candid about the branch-plant economy, where Canadians become the worker bees while the real value flows elsewhere, and why every foreign investment should face one question: where does the IP live? When CCI loses members, he says, it's usually because a US acquirer or investor pulls the leadership team south.

On healthcare, Perry calls it a national security asset. He points to CCI's Care at Scale report, which estimates that better, more portable health data could save up to $2.4 billion a year, and warns that Canadian health data stored on foreign servers can be reached by foreign governments — making Canadian-built "maple stack" infrastructure a sovereignty issue. He closes with CCI's budget priorities: a Canadian QSBS, a startup visa, a Buy Canada policy that supports genuinely Canadian companies rather than those Canadian in name only, and a reminder, borrowed from Red Green, that we're all in this together — but duct tape won't fix it this time.

This is Breaking Innovation Paralysis: research for a book on why Canada keeps losing the cures, capital, and companies it builds. Not a promotional platform, an honest look at the structural gaps: inertia, risk aversion, and diffusion of responsibility.

If this shifted how you think about Canada's innovation gap, share it with someone who needs to hear it.

🎧 New episodes weekly. Subscribe for more honest conversations with the people building, gatekeeping, and navigating Canada's innovation journey.

🔗 Questions, feedback, or want to connect? https://augmentios.com/contact

📩 Subscribe to my LinkedIn Newsletter: https://bit.ly/BIPLinkedInNewsletter

#BreakingInnovationParalysis #CanadianInnovation #InnovationEcosystem #LifeSciences #InnovationPolicy #Procurement #HealthData #EconomicSovereignty


More episodes from "Breaking Innovation Paralysis"